JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schechter, N. R.
Right arrow Articles by Ang, K. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schechter, N. R.
Right arrow Articles by Ang, K. K.

Radiation Dosimetry of 99mTc-Labeled C225 in Patients with Squamous Cell Carcinoma of the Head and Neck

Naomi R. Schechter, MD1, Richard E. Wendt, III, PhD2, David J. Yang, PhD2, Ali Azhdarinia, MS2, William D. Erwin, MS2, Anne M. Stachowiak, AAS2, Lyle D. Broemeling, PhD3, E. Edmund Kim, MD2, James D. Cox, MD1, Donald A. Podoloff, MD2 and K. Kian Ang, MD, PhD1

1 Division of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
2 Division of Diagnostic Imaging, University of Texas M.D. Anderson Cancer Center, Houston, Texas
3 Division of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, Texas



View larger version (83K):

[in a new window]
  		FIGURE 1. Whole-body coronal images obtained 2, 4, and 6 h (from left to right) after administration of 851 MBq of 99mTc-EC-C225 to a patient with squamous cell carcinoma of the head and neck—the first patient scanned with this compound.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.